Research Pharmaceuticals and Intermediates

Pharmaceuticals are useful tools for mechanism of action studies in many ways. Besides being enzyme inhibitors, receptor agonists or antagonists, channel blockers, neurotransmitters themselves, they are used to compare and define other emerging compounds for their prospective applications.

  • Group 1
  • Group 2
  • Group 3
  • Group 4
  • Group 5
  • Group 6
  • Others
  • Group 2

    Structure Details
    Product Name: Irinotecan hydrochloride trihydrate, 98
    Order number: 50P987783
    CAS: 136572-09-3
    Purity: >=95%
    Appearance: solid
    MF: C33H45ClN4O9
    MW: 677.192
    MP: 250-256 (dec.) oC

    Description:
    This compound is an analog of camptothecin. Irinotecan competes for binding to DNA strand to prevent formation of topoisomerase I-DNA complex, thereby causing double-strand DNA breakage.
    Product Name: Erlotinib
    Order number: 100779
    CAS: 183319-69-9
    Purity: >=95%
    Appearance: solid
    MF: C22H24ClN3O4
    MW: 429.901
    MP: 228-230 (M.I.) oC

    Description:
    It is in the tyrosine kinase receptor inhibitor class of medications.
    Product Name: SB203580
    Order number: 101038
    CAS: 152121-47-6
    Purity: >=95%
    Appearance: solid
    MF: C21H16FN3OS
    MW: 377.437
    MP: n.a. oC

    Description:
    This substance is a highly selective inhibitor of p38 MAP kinase, competing with ATP for binding to p38.
    Product Name: Etoposide phosphate
    Order number: 212082
    CAS: 117091-64-2
    Purity: 98(HPLC)%
    Appearance: n.a.
    MF: C29H33O16P
    MW: 668.5
    MP: n.a. oC

    Description:
    It inhibits DNA synthesis.